Evidera
Sabina Saini possesses extensive experience in medical writing and healthcare communications, currently serving as a Principal Medical Information Writer at Evidera since January 2017, following a progression to this role from a Senior Medical Information Writer. Prior experience includes key positions at PPD as a Senior Medical Information Writer and Medical Information Writer, as well as a role as a Medical Information Scientist at Novo Nordisk A/S. Additionally, Sabina has held positions at Bristol-Myers Squibb, Horizon Blue Cross Blue Shield of NJ, and various pharmacy roles. Sabina Saini holds a Pharm.D. degree from Rutgers University, completed in 2008.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.